Skip to main content
Clinical Trials/CTRI/2024/12/078374
CTRI/2024/12/078374Not yet recruitingPhase 2

Simultaneous or sequential use of Foley’s catheter and oxytocin for induction of labour -Randomised controlled trial

Dr Swati sharma1 site in 1 country90 target enrollmentStarted: December 29, 2024Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
90
Locations
1
Primary Endpoint
to determine induction to delivery interval and compare it in both groups

Study Overview

Brief Summary

we aim to determine whether simultaneous use of Foley’s and oxytocin will be advantageous to achieve vaginal delivery after IOL without an increase in the oxytocin to delivery interval or the CS rate as compared to sequential use. If found beneficial, it will reduce overnight hospital stay for cervical ripening with Foley’s kept for 12 hours.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 45.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • 1.Gestational age greater than 34 weeks 2.Bishops score six or less 3.Single live fetus with cephalic presentation 4.Intact membranes 5.Reactive non stress test (NST).

Exclusion Criteria

  • 1.Previous uterine scar (caesarean section or myomectomy) 2.Parity greater than 3 3.Fetal congenital malformations 4.Severe fetal growth restriction(estimated fetal weight less than 3rd centile and/or abnormal Doppler changes in umbilical artery ) 5.Pre-eclampsia with severe features /eclampsia 6.Antepartum haemorrhage 7.Premature rupture of membranes (PROM) 8.Cervicovaginal infections 9.Medical disorders (heart disease, seizure disorder, severe anaemia, renal disease, uncontrolled diabetes, uncontrolled hypertension, retropositive status).

Outcomes

Primary Outcomes

to determine induction to delivery interval and compare it in both groups

Time Frame: 11 months

Secondary Outcomes

  • 1. Caesarean section (CS) rate 2. Incidence of uterine contraction abnormalities 3. Infectious morbidity in the mother (chorioamnionitis or puerperal sepsis) 4. Composite Neonatal outcome(11 months)

Investigators

Sponsor
Dr Swati sharma
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Swati sharma

PGIMER Chandigarh

Study Sites (1)

Loading locations...

Similar Trials